These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11870441)

  • 21. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
    Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone complications in children with Gaucher disease.
    Bembi B; Ciana G; Mengel E; Terk MR; Martini C; Wenstrup RJ
    Br J Radiol; 2002; 75 Suppl 1():A37-44. PubMed ID: 12036831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organ volume by computed tomography correlates with longitudinal axis on ultrasound in patients with Gaucher disease.
    Elstein D; Tiomkin M; Hadas-Halpern I; Zimran A
    Ultrasound Q; 2011 Dec; 27(4):225-8. PubMed ID: 22124387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scintigraphic monitoring of reticuloendothelial system in patients with type 1 Gaucher disease on enzyme replacement therapy.
    Lorberboym M; Pastores GM; Kim CK; Hermann G; Glajchen N; Machac J
    J Nucl Med; 1997 Jun; 38(6):890-5. PubMed ID: 9189137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S; Roberts A; Patterson MA; Amato D
    Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone manifestations in neuronopathic Gaucher disease while receiving high-dose enzyme replacement therapy.
    Potnis KC; Flueckinger LB; Ha CI; Upadia J; Frush DP; Kishnani PS
    Mol Genet Metab; 2019 Feb; 126(2):157-161. PubMed ID: 30448006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease.
    Mitrovic M; Antic D; Elezovic I; Janic D; Miljic P; Sumarac Z; Nikolic T; Suvajdzic N
    Platelets; 2012; 23(2):143-9. PubMed ID: 21767238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gaucher disease: sonographic appearance of the spleen.
    Hill SC; Reinig JW; Barranger JA; Fink J; Shawker TH
    Radiology; 1986 Sep; 160(3):631-4. PubMed ID: 3526400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM; Pastores GM; Ware JE
    Qual Life Res; 1998 Jul; 7(5):373-86. PubMed ID: 9691718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease.
    Lin HY; Lin SP; Chuang CK; Wraith JE
    J Chin Med Assoc; 2006 May; 69(5):228-32. PubMed ID: 16835986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1.
    Andersson H; Kaplan P; Kacena K; Yee J
    Pediatrics; 2008 Dec; 122(6):1182-90. PubMed ID: 19047232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gaucher's disease suspected by abdominal echography findings].
    Castellano G; Yela MC; Martín A; Manzano ML; Colina F; Solís JA
    Gastroenterol Hepatol; 1998 Apr; 21(4):184-7. PubMed ID: 9633179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease.
    Regenboog M; Bohte AE; Somers I; van Delden OM; Maas M; Hollak CE
    Blood Cells Mol Dis; 2016 Sep; 60():49-57. PubMed ID: 27519945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
    Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
    Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin abnormalities and effects of enzyme replacement therapy in children with Gaucher disease.
    Arıkan-Ayyıldız Z; Yuce A; Uslu-Kızılkan N; Demir H; Gurakan F
    Pediatr Blood Cancer; 2011 Apr; 56(4):664-6. PubMed ID: 21298757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report of unexpected gastrointestinal involvement in type 1 Gaucher disease: comparison of eliglustat tartrate treatment and enzyme replacement therapy.
    Kim YM; Shin DH; Park SB; Cheon CK; Yoo HW
    BMC Med Genet; 2017 May; 18(1):55. PubMed ID: 28506293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
    Pastores GM; Barnett NL; Kolodny EH
    Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
    Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
    Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the densitometric method of hand bone radiograms and assessment of early changes of bone structure in the children with Gaucher s disease on enzyme replacement therapy (ERT)].
    Lysoń-Wojciechowska G; Skawiński W; Tylki-Szymańska A
    Pediatr Endocrinol Diabetes Metab; 2007; 13(3):159-64. PubMed ID: 17880827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal changes of the spleen in one case of Gaucher disease--assessed by ultrasonography, CT, MRI and angiography.
    Aspestrand F; Charania B; Scheel B; Kolmannskog F; Jacobsen M
    Radiologe; 1989 Nov; 29(11):569-71. PubMed ID: 2685891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.